Krsnaa Diagnostics Limited — Updates, 11-08-2025: Press Release

Krsnaa Diagnostics delivered strong Q1 FY26 results. Revenue surged 13% YoY to ₹193 Cr, driven by expanding patient trust. EBITDA grew 19% to ₹52.4 Cr, with a healthy 27% margin, while Net Profit increased 15% to ₹20.5 Cr. A significant milestone was achieved by securing a landmark pathology project in Rajasthan, which includes establishing 42 Mother Labs, 135 Satellite Labs, and over 1,300 Collection Centers. The company also expanded its national footprint with 75 new centers and experienced a 7.9x jump in retail revenue across 2,414 locations.